ARTICLE | Company News
Rosetta Genomics, Admera Health sales and marketing update
May 4, 2015 7:00 AM UTC
Rosetta launched Admera’s laboratory developed test (LDT), OncoGxOne to detects alterations in 64 genes implicated in cancer and chemotherapy. Rosetta has rights to the test under a 2014 deal. ...